BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 214 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2023. The put-call ratio across all filers is 2.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,657,523 | -24.9% | 52,918 | -5.5% | 0.00% | 0.0% |
| Q2 2023 | $3,537,848 | +74.1% | 55,979 | +24.0% | 0.00% | 0.0% |
| Q1 2023 | $2,031,687 | +2.9% | 45,158 | +0.2% | 0.00% | – |
| Q4 2022 | $1,974,473 | +213.9% | 45,069 | +372.0% | 0.00% | – |
| Q3 2022 | $629,000 | +23.1% | 9,548 | -5.6% | 0.00% | – |
| Q2 2022 | $511,000 | -80.9% | 10,118 | -75.8% | 0.00% | -100.0% |
| Q1 2022 | $2,675,000 | -61.5% | 41,869 | -35.5% | 0.00% | -50.0% |
| Q4 2021 | $6,954,000 | -18.7% | 64,928 | -21.9% | 0.00% | 0.0% |
| Q3 2021 | $8,551,000 | +19.3% | 83,176 | +2.0% | 0.00% | 0.0% |
| Q2 2021 | $7,170,000 | -20.3% | 81,511 | -11.9% | 0.00% | 0.0% |
| Q1 2021 | $8,999,000 | +29.7% | 92,555 | +49.6% | 0.00% | 0.0% |
| Q4 2020 | $6,939,000 | +69.7% | 61,871 | +40.3% | 0.00% | +100.0% |
| Q3 2020 | $4,088,000 | -3.9% | 44,102 | -19.1% | 0.00% | 0.0% |
| Q2 2020 | $4,252,000 | +53.9% | 54,500 | -0.8% | 0.00% | 0.0% |
| Q1 2020 | $2,762,000 | -5.2% | 54,955 | +51.0% | 0.00% | 0.0% |
| Q4 2019 | $2,915,000 | -5.6% | 36,389 | -13.4% | 0.00% | 0.0% |
| Q3 2019 | $3,088,000 | -20.6% | 42,034 | +1.9% | 0.00% | 0.0% |
| Q2 2019 | $3,891,000 | +42.6% | 41,253 | +21.0% | 0.00% | 0.0% |
| Q1 2019 | $2,729,000 | +52.2% | 34,093 | +2.5% | 0.00% | 0.0% |
| Q4 2018 | $1,793,000 | -29.8% | 33,253 | +1.6% | 0.00% | 0.0% |
| Q3 2018 | $2,554,000 | +103.0% | 32,718 | +65.1% | 0.00% | – |
| Q2 2018 | $1,258,000 | -46.9% | 19,815 | -44.8% | 0.00% | -100.0% |
| Q1 2018 | $2,368,000 | +29.9% | 35,922 | +48.6% | 0.00% | 0.0% |
| Q4 2017 | $1,823,000 | -37.2% | 24,178 | -41.9% | 0.00% | 0.0% |
| Q3 2017 | $2,901,000 | +98.4% | 41,638 | +44.4% | 0.00% | – |
| Q2 2017 | $1,462,000 | +66.7% | 28,827 | +31.5% | 0.00% | – |
| Q1 2017 | $877,000 | +99.8% | 21,928 | +40.2% | 0.00% | – |
| Q4 2016 | $439,000 | +116.3% | 15,642 | +128.6% | 0.00% | – |
| Q3 2016 | $203,000 | +46.0% | 6,842 | 0.0% | 0.00% | – |
| Q2 2016 | $139,000 | +95.8% | 6,842 | +72.7% | 0.00% | – |
| Q1 2016 | $71,000 | -15.5% | 3,962 | +24.9% | 0.00% | – |
| Q4 2015 | $84,000 | +23.5% | 3,171 | -0.4% | 0.00% | – |
| Q3 2015 | $68,000 | +466.7% | 3,185 | +579.1% | 0.00% | – |
| Q2 2015 | $12,000 | – | 469 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
| DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
| Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
| Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
| Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
| CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
| SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
| Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
| EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |